Results 21 to 30 of about 27,643 (258)

A Case of Intestinal Granular Calcifications Associated With Phosphate Binder Use in a Patient on Hemodialysis [PDF]

Clinical Case Reports
An experienced physician correctly identified a high‐intensity intestinal X‐ray from Lanthanum Carbonate, preventing unnecessary tests and enabling proper treatment. Awareness of this is vital in managing renal failure patients.
Takaaki Nagao, Yosuke Azuma, Ryo Ichibayashi   +2 more
doaj   +2 more sources

Prevention and treatment of hyperphosphatemia in chronic kidney disease

Kidney International, 2018
Marc G Vervloet, Adriana J Van Ballegooijen   +1 more
exaly   +2 more sources

Dietary Therapy for Managing Hyperphosphatemia [PDF]

American Society of Nephrology. Clinical Journal, 2020
Yoko Narasaki, Connie M. Rhee
openalex   +2 more sources

Patiromer Treatment in Patients With CKD, Hyperkalemia, and Hyperphosphatemia: A Post Hoc Analysis of 3 Clinical Trials.

American Journal of Kidney Diseases, 2023
RATIONALE & OBJECTIVE Patients with chronic kidney disease (CKD), hyperkalemia (serum potassium [sK+] >5.0 mEq/L), and hyperphosphatemia experience poor clinical outcomes.
D. Bushinsky, J. Budden, P. Kalra, Jinwei Yuan, C. M. Quinn, Murray Epstein   +5 more
semanticscholar   +1 more source

Estrogen inhibits renal Na-Pi Co-transporters and improves klotho deficiency-induced acute heart failure

Redox Biology, 2021
Objective and hypothesis: Klotho is an aging-suppressor gene. Mutation of Klotho gene causes hyperphosphatemia and acute heart failure. However, the relationship of hyperphosphatemia and acute heart failure is unclear.
Kai Chen, Zhongjie Sun
doaj   +1 more source

Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches

Medicina, 2023
Hyperphosphatemia is a secondary disorder of chronic kidney disease that causes vascular calcifications and bone-mineral disorders. As per the US Centers for Disease Control and Prevention, renal damage requires first-priority medical attention for ...
Ajeeta Anand, Hideki Aoyagi
doaj   +1 more source

Effectiveness of a Nutritional Mobile Application for Management of Hyperphosphatemia in Patients on Hemodialysis: A Multicenter Open-Label Randomized Clinical Trial

Journal of Personalized Medicine, 2022
This study aims to determine the effectiveness of a phosphate mobile app (PMA), MyKidneyDiet-Phosphate Tracker ©2019, on hemodialysis (HD) patients with hyperphosphatemia.
Lee-Fang Teong, B. Khor, H. Ng, S. Sahathevan, Kristo Radion Purba, S. Narayanan, A. Gafor, B. Goh, B. Bee, R. Yahya, S. Bavanandan, Zaimi Wahab, S. A. Mazlan, K. Chinna, Z. Morad, Z. M. Daud, T. Karupaiah   +16 more
semanticscholar   +1 more source

Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome

Journal of Bone and Mineral Research, 2016
Pravitt Gourh, Raphaela T Goldbach-Mansky, Shoji Ichikawa   +2 more
exaly   +2 more sources

Phosphate intake, hyperphosphatemia, and kidney function

Pflügers Archiv: European Journal of Physiology, 2022
Phosphate is essential in living organisms and its blood levels are regulated by a complex network involving the kidneys, intestine, parathyroid glands, and the skeleton.
I. Rubio-Aliaga, R. Krapf
semanticscholar   +1 more source

Spurious Hyperphosphatemia in a Patient with Multiple Myeloma: A Case Report

Journal of Health Science and Medical Research (JHSMR), 2021
Spurious hyperphosphatemia has been reported periodically in multiple myeloma (MM) patients with paraproteinemia. It is important for clinicians to recognize this phenomenon in order to avoid misdiagnosis and unnecessary treatment for true ...
Thakorn Pruktanakul, Rattana Leelawattana   +1 more
doaj   +1 more source